ŠŤASTNÁ, Nela, Kristián BRAT, Lukáš HOMOLA, Audun OS a Dagmar BRANČÍKOVÁ. Increasing incidence rate of breast cancer in cystic fibrosis-relationship between pathogenesis, oncogenesis and prediction of the treatment effect in the context of worse clinical outcome and prognosis of cystic fibrosis due to estrogens. Orphanet Journal of Rare Diseases. London: England, 2023, roč. 18, č. 1, s. 1-7. ISSN 1750-1172. Dostupné z: https://dx.doi.org/10.1186/s13023-023-02671-z.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Increasing incidence rate of breast cancer in cystic fibrosis-relationship between pathogenesis, oncogenesis and prediction of the treatment effect in the context of worse clinical outcome and prognosis of cystic fibrosis due to estrogens
Autoři ŠŤASTNÁ, Nela (203 Česká republika, garant, domácí), Kristián BRAT (703 Slovensko, domácí), Lukáš HOMOLA (203 Česká republika, domácí), Audun OS a Dagmar BRANČÍKOVÁ (203 Česká republika, domácí).
Vydání Orphanet Journal of Rare Diseases, London, England, 2023, 1750-1172.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30203 Respiratory systems
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 3.700 v roce 2022
Kód RIV RIV/00216224:14110/23:00130751
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1186/s13023-023-02671-z
UT WoS 000956257500001
Klíčová slova anglicky Cystic fibrosis; Breast cancer; Estrogens; Anticancer treatment; CFTR modulator therapy
Štítky 14110212, 14110215, 14110318, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 10. 5. 2023 14:13.
Anotace
Cystic fibrosis (CF) is the most common genetic disease in the Caucasion population. Thanks to the CFTR modulators therapy, life expectancy will significantly improve. New therapeutic challenges can be expected, including diseases associated with ageing and higher incidence of cancer, as evidenced by recent epidemiological studies. The increasing incidence of tumors includes also breast cancer. The risk of breast cancer is higher in CF patients compared to the general population. Sex hormones, especially estrogens, also affect on the pathophysiology and immunology of the CF. Previous research, has demonstrated unequivocal survival rates for female CF patients compared to their male counterparts. Is demonstrated, that chemotherapy used for breast cancer affects the CFTR channel and CFTR modulator therapy has frequent side effects on breast tissue. In this review, we focus on the effects of female sex hormones on CF disease, pathophysiological relationships between CF and breast cancer, and the impact of antitumor treatment on both, malignant disease and CF. The potential for further investigation is also discussed.
VytisknoutZobrazeno: 28. 4. 2024 01:03